Why is Jubilant Ingrev. falling/rising?
As of 03-Jul, Jubilant Ingrevia Ltd's stock price is 781.55, reflecting a 1.05% increase and a total return of 4.01% over the last four days. The stock has outperformed its sector and generated a 48.57% return over the past year, supported by strong financial health and high institutional confidence.
As of 03-Jul, Jubilant Ingrevia Ltd's stock price is currently at 781.55, reflecting an increase of 8.1, or 1.05%. The stock has been on an upward trend, gaining for the last four consecutive days and achieving a total return of 4.01% during this period. It has outperformed its sector by 0.57% today, and it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a remarkable return of 48.57%, significantly surpassing the market's performance. Additionally, the company has demonstrated strong financial health with a low Debt to EBITDA ratio of 0.91 times and impressive growth in net profit, which has positively influenced investor sentiment.In the broader market context, Jubilant Ingrevia's short-term return of 1.65% over the past week stands in stark contrast to the Sensex, which has declined by 0.62%. This indicates that the stock is not only performing well on its own but is also gaining traction relative to the market. Despite a slight decrease in delivery volume, which fell by 9.96% against the 5-day average, the stock remains liquid enough for trading. The high institutional holdings at 23.04% suggest that knowledgeable investors are confident in the company's fundamentals, further supporting the stock's upward movement.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
